When it comes to prostate MRI, experience matters. Discover why choosing an expert with a proven track record can make all the difference in accurate, reliable results. keep reading
Let’s face it, guys. We’re not getting any younger. In fact, society is getting older. The Population Reference Bureau tells us that in the U.S, the number of those age 65 and up is expected to nearly double from 52 million in 2018 to 95 million by 2060... keep reading
Does PSA screening reduce PCa mortality, or doesn’t it? We know that PSA is not specific for cancer, since many prostate conditions can cause a rise in PSA blood levels. We also know that an elevated PSA can lead to a conventional TRUS-guided biopsy, and that such biopsies can either miss prostate cancer or... keep reading
Artificial Intelligence is transforming prostate MRI interpretation, making it faster and more precise. See how this breakthrough technology is elevating prostate health diagnostics. keep reading
Understanding erectile dysfunction can lead to better health and confidence. Discover five key facts about ED and how you can take control for a happier, healthier life. keep reading
A frequent concern of patients who come to our Center for focal laser ablation is the risk of side effects from whole gland treatments. Men commonly tell me things like: “I don’t want surgery because I don’t want to wear diapers, even temporarily.” “I don’t think the urologist is telling me all the facts about keep reading
The Reverend Jesse Jackson described the American dream as one big tent: “And on that big tent you have four basic promises: equal protection under the law, equal opportunity, equal access, and fair share.” A new study suggests that when it comes to prostate cancer (PCa), patients do not have equal access to medical care. keep reading
Four thousand five hundred seventy-seven prostate cancer patients can’t be wrong. At least, a study in the Journal of the American Medical Association (JAMA) reported some interesting findings after tracking that many men with non-metastatic prostate cancer between 1986-2010. Those men who replaced 10% of their total daily calories from carbohydrates with healthy fats from keep reading
Four thousand five hundred seventy-seven prostate cancer patients can’t be wrong. At least, a study in the Journal of the American Medical Association (JAMA) reported some interesting findings after tracking that many men with non-metastatic prostate cancer between 1986-2010. Those men who replaced 10% of their total daily calories from carbohydrates with healthy fats from keep reading
An international team of experts on imaging prostate cancer participated in a review of the literature on prostate MRI and active surveillance.[i] To give you an idea of how impressive the team was, here is a list of the institutions they represent: Erasmus University Medical Center (Depts. of Urology and Radiology), Rotterday, the Netherlands University keep reading
Sadly, prostate cancer (PCa) patients with low-risk disease are still being sent for needless diagnostic bone and CT scans. This was the finding of an impressive multi-disciplinary research team from several institutions (U.S. Veterans Administration and various medical and public policy departments within New York University and Yale University). The investigators found that nearly keep reading
“There is increased use of radiotherapy among patients with indolent prostate cancer with limited to no correlation with tumor biology.” This conclusion was reached by a research team out of UCLA after studying the treatment choices of 37,621 patients.[i] In fact, over half (57.9%) of the men were sent for radiation, while 19.1% had a keep reading
In 2012, the U.S. Preventive Services Task Force (USPSTF) issued a recommendation against routine PSA screening for otherwise healthy men. Almost immediately, prostate cancer support organizations and hundreds of clinical professionals raised an outcry. While acknowledging that the non-prostate cancer specific blood test often led to over-detection and over-treatment of indolent prostate cancer, countless lives keep reading
A man who is suspected of having prostate cancer, or whose cancer has been biopsy confirmed, can develop the best right treatment plan if he also has a multiparametric MRI (mpMRI) of the prostate. When his own doctor sends him to an imaging center, his scan is “read” by the center’s radiologist who writes a keep reading
It seems intuitive, if not obvious, that superior imaging of the prostate gives precise information to guide a biopsy needle into a cancerous tumor. The typical ultrasound imaging used by urologists in their offices is inferior to magnetic resonance imaging (MRI). Ultrasound-guided transrectal (TRUS) biopsy has a minimum 35% chance of missing cancer. If our keep reading
